← Leaderboards
Kimberly Page
University Of California San Francisco
$27,276,464
Attributed
$28,582,008
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,612,221 · 13
CDC$2,742,405 · 3
By mechanism
R01$22,508,336 · 6
UG1$13,694,129 · 5
U01$2,119,478 · 1
U18$899,906 · 1
U54$755,000 · 1
R03$249,171 · 1
Top collaborators
- Ellen Stein3 shared
- Karla D. Wagner3 shared
- Maria Adela Grando1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Frances M Brodsky$9,589,926
- Morton Cowan$11,226,923
- David V Glidden$1,931,701
- Elise D Riley$16,115,559
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchPreventionCaringCommunitiesEpidemicAffectUptakeUniversitiesIncidenceNational Institute Of Drug AbuseHepatitis CProspectiveInfectionResearch PersonnelGenderPlayRisk BehaviorsPersonsBiologicalFundingSex BehaviorHepatitis C VirusResearch StudyWoman
Grant awards (68)
Southwest Clinical Trials Node: Clinical Research and Practice to Address Substance Use in Diverse, Rural, and Underserved Populations$783,906
UG1 · FY2025 · DA · contact PI
Project-004$1,440,775
UG1 · FY2023 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$1,071,836
UG1 · FY2023 · DA · contact PI
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West$362,500
R01 · FY2023 · CE
Project-003$235,580
UG1 · FY2023 · DA · contact PI
Project-002$179,294
UG1 · FY2023 · DA · contact PI
Project-005$65,862
UG1 · FY2023 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$941,000
UG1 · FY2022 · DA · contact PI
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West$362,500
R01 · FY2022 · CE
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$358,473
UG1 · FY2022 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$1,936,681
UG1 · FY2021 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$735,149
UG1 · FY2021 · DA · contact PI
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West$362,499
R01 · FY2021 · CE
Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials$220,751
UG1 · FY2021 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$145,109
UG1 · FY2021 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$2,679,320
UG1 · FY2020 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$148,594
UG1 · FY2020 · DA · contact PI
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations$2,751,799
UG1 · FY2019 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,268,832
R01 · FY2018 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,358,160
R01 · FY2017 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,373,874
R01 · FY2016 · DA · contact PI
Cambodia Integrated HIV and Drug Prevention Implementation Program$489,862
R01 · FY2016 · DA
Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico$299,996
U18 · FY2016 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$99,999
R01 · FY2016 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,330,280
R01 · FY2015 · DA · contact PI
Cambodia Integrated HIV and Drug Prevention Implementation Program$505,903
R01 · FY2015 · DA
International Collaborative of prospective studies of HIV and Hepatitis in IDU$386,153
R01 · FY2015 · DA · contact PI
Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico$299,937
U18 · FY2015 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$119,766
R01 · FY2015 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,332,959
R01 · FY2014 · DA · contact PI
Cambodia Integrated HIV and Drug Prevention Implementation Program$527,824
R01 · FY2014 · DA
International Collaborative of prospective studies of HIV and Hepatitis in IDU$457,155
R01 · FY2014 · DA · contact PI
Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico$299,973
U18 · FY2014 · PS · contact PI
International Collaborative of prospective studies of HIV and Hepatitis in IDU$69,686
R01 · FY2014 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$757,294
R01 · FY2013 · DA · contact PI
Cambodia Integrated HIV and Drug Prevention Implementation Program$524,803
R01 · FY2013 · DA · contact PI
International Collaborative of prospective studies of HIV and Hepatitis in IDU$413,985
R01 · FY2013 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$1,027,825
R01 · FY2012 · DA · contact PI
Cambodia Integrated HIV and Drug Prevention Implementation Program$570,047
R01 · FY2012 · DA · contact PI
International Collaborative of prospective studies of HIV and Hepatitis in IDU$438,391
R01 · FY2012 · DA · contact PI
HCV PREVENTION AND CARE EDUCATION$150,000
U54 · FY2012 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$992,772
R01 · FY2011 · DA · contact PI
International Collaborative of prospective studies of HIV and Hepatitis in IDU$483,785
R01 · FY2011 · DA · contact PI
Culture and HIV Prevention in Cambodia$296,754
R01 · FY2011 · NR · contact PI
HCV PREVENTION AND CARE EDUCATION$150,000
U54 · FY2011 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$968,688
R01 · FY2010 · DA · contact PI
Culture and HIV Prevention in Cambodia$397,108
R01 · FY2010 · NR · contact PI
HCV PREVENTION AND CARE EDUCATION$150,000
U54 · FY2010 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$762,260
R01 · FY2009 · DA · contact PI
Culture and HIV Prevention in Cambodia$423,486
R01 · FY2009 · NR · contact PI
HCV PREVENTION AND CARE EDUCATION$155,000
U54 · FY2009 · PS · contact PI
Acute Hepatitis C Infection in Young Injectors$466,965
R01 · FY2008 · DA · contact PI
HCV PREVENTION AND CARE EDUCATION$150,000
U54 · FY2008 · PS · contact PI
ATS Use & HIV Among Young Female Sex and Entertainment Workers in Cambodia$128,606
R21 · FY2008 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$486,800
R01 · FY2007 · DA · contact PI
Acute Hepatitis C Infection in Young Injectors$505,801
R01 · FY2006 · DA · contact PI
Phase 1/2 trial of Pharmacological HIV-1 Prevention$737,854
U01 · FY2005 · AI
Acute Hepatitis C Infection in Young Injectors$531,098
R01 · FY2005 · DA
Phase 1/2 trial of Pharmacological HIV-1 Prevention$957,316
U01 · FY2004 · AI
HCV Infection &Treatment in Parolees: Feasibility Study$124,565
R03 · FY2004 · DK
Phase 1/2 trial of Pharmacological HIV-1 Prevention$424,308
U01 · FY2003 · AI
Acute Hepatitis C Infection in Young Injectors$303,823
R01 · FY2003 · DA
ORAL ACQUISITION OF HIV INFECTION$264,071
R01 · FY2003 · DE
HCV Infection &Treatment in Parolees: Feasibility Study$124,606
R03 · FY2003 · DK
ORAL ACQUISITION OF HIV INFECTION$391,604
R01 · FY2002 · DE
Acute Hepatitis C Infection in Young Injectors$310,536
R01 · FY2002 · DA
ORAL ACQUISITION OF HIV INFECTION$395,784
R01 · FY2001 · DE
ORAL ACQUISITION OF HIV INFECTION$386,704
R01 · FY2000 · DE